Event Abstract

Myeloperoxidase-deficiency protects from ventricular tachycardia in a murine model of ischemic cardiomyopathy

  • 1 University of Cologne, Cologne Cardiovascular Research Center, Germany
  • 2 University of Cologne, Cologne Cardiovascular Research Center, Germany
  • 3 University of Cologne, Cologne Cardiovascular Research Center, Germany

Motivation: Leukocytes have emerged as important mediators of adverse myocardial remodeling following myocardial infarction. Myeloperoxidase (MPO), a heme enzyme abundantly expressed and released by polymorphonuclear neutrophils (PMN), exerts pro-inflammatory and pro-fibrotic properties and has been identified to be causally linked to the formation and propagation of various cardiovascular disorders. We disclosed recently, that MPO critically promotes atrial fibrosis and arrhythmias. Thus, we sought to investigate whether MPO might also influence structural and electrical remodelling in ventricular myocardium. Methods and Results: Wild-type C57bl/6J (WT) and MPO-deficient (Mpo-/-) mice underwent either sham surgery (n=7, 6) or ligation of the left descending coronary artery (LAD) (n=7, 5). Right ventricular electrophysiological investigations 3 weeks after LAD ligation disclosed profoundly increased vulnerability for ventricular tachycardia (VT) in infarcted WT as compared to Mpo-/- mice (number of VT episodes: 6.7 ± 1.3 vs. 1.8 ± 0.9, p<0.01, sham: 2.0 ± 0.4 vs. 1.7 ± 0.8, p = 0.79; total time of VT episodes: 3.67 ± 0.88 vs. 0.88 ± 0.36 sec, p<0.05, sham: 0.70 ± 0.18 vs. 1.07 ± 0.75 sec, p = 0.67). Epicardial mapping analyses indicated a delayed velocity and enhanced heterogeneity of electrical conduction in WT as compared to Mpo-/- mice. No differences were observed in infarct size between WT and Mpo-/- mice, as assessed by hematoxylin/eosin stain of myocardial sections. Conclusions: The current data demonstrate, that MPO increases the vulnerability for ventricular arrhythmias in a murine model of ischemic cardiomyopathy. Whereas no differences were observed in infarct size, characteristics of electrical conduction pointed to aggravated adverse electrical or structural remodeling in WT as compared to Mpo-/- mice. While the underlying mechanisms still have to be elucidated, the results underline the important role of inflammatory processes in cardiac remodeling upon myocardial infarction and identify MPO as a potential therapeutic target to prevent ventricular arrhythmias in ischemic cardiomyopathy.

Keywords: Tachycardia, Myeloperoxidase, ICM

Conference: MEA Meeting 2016 | 10th International Meeting on Substrate-Integrated Electrode Arrays, Reutlingen, Germany, 28 Jun - 1 Jul, 2016.

Presentation Type: Poster Presentation

Topic: MEA Meeting 2016

Citation: Mollenhauer M, Lange M, Klinke A, Friedrichs K, Rudolph TK, Baldus S and Rudolph V (2016). Myeloperoxidase-deficiency protects from ventricular tachycardia in a murine model of ischemic cardiomyopathy. Front. Neurosci. Conference Abstract: MEA Meeting 2016 | 10th International Meeting on Substrate-Integrated Electrode Arrays. doi: 10.3389/conf.fnins.2016.93.00110

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 22 Jun 2016; Published Online: 24 Jun 2016.

* Correspondence: Dr. Martin Mollenhauer, University of Cologne, Cologne Cardiovascular Research Center, Köln, Germany, martin.mollenhauer@uk-koeln.de